Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
2.800
-0.100 (-3.45%)
At close: Jan 12, 2026, 4:00 PM EST
2.880
+0.080 (2.86%)
Pre-market: Jan 13, 2026, 9:07 AM EST
Treace Medical Concepts Revenue
Treace Medical Concepts had revenue of $50.21M in the quarter ending September 30, 2025, with 11.37% growth. This brings the company's revenue in the last twelve months to $218.88M, up 7.90% year-over-year. In the year 2024, Treace Medical Concepts had annual revenue of $209.36M with 11.89% growth.
Revenue (ttm)
$218.88M
Revenue Growth
+7.90%
P/S Ratio
0.80
Revenue / Employee
$458,866
Employees
477
Market Cap
178.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 209.36M | 22.24M | 11.89% |
| Dec 31, 2023 | 187.12M | 45.28M | 31.92% |
| Dec 31, 2022 | 141.84M | 47.42M | 50.22% |
| Dec 31, 2021 | 94.42M | 37.05M | 64.59% |
| Dec 31, 2020 | 57.37M | 17.95M | 45.54% |
| Dec 31, 2019 | 39.42M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TMCI News
- 2 hours ago - Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue - GlobeNewsWire
- 4 days ago - Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - GlobeNewsWire
- 26 days ago - Treace Medical Secures Up to $175 Million in Debt Financing - GlobeNewsWire
- 2 months ago - Treace Medical Concepts, Inc. (TMCI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Treace Announces Participation in Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Treace to Report Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire
- 4 months ago - Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting - GlobeNewsWire
- 4 months ago - Treace Medical Concepts, Inc. (TMCI) Investor Day 2025 Call Transcript - Seeking Alpha